212 related articles for article (PubMed ID: 33258906)
1. Cost-effectiveness of Screening for Osteoporosis in Older Men With a History of Falls.
Ito K
JAMA Netw Open; 2020 Dec; 3(12):e2027584. PubMed ID: 33258906
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of different screening strategies for osteoporosis in postmenopausal women.
Nayak S; Roberts MS; Greenspan SL
Ann Intern Med; 2011 Dec; 155(11):751-61. PubMed ID: 22147714
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men.
Schousboe JT; Taylor BC; Fink HA; Kane RL; Cummings SR; Orwoll ES; Melton LJ; Bauer DC; Ensrud KE
JAMA; 2007 Aug; 298(6):629-37. PubMed ID: 17684185
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of fracture prevention in rural women with limited access to dual-energy X-ray absorptiometry.
Ito K; Leslie WD
Osteoporos Int; 2015 Aug; 26(8):2111-9. PubMed ID: 25807913
[TBL] [Abstract][Full Text] [Related]
5. A model-based cost-effectiveness analysis of osteoporosis screening and treatment strategy for postmenopausal Japanese women.
Yoshimura M; Moriwaki K; Noto S; Takiguchi T
Osteoporos Int; 2017 Feb; 28(2):643-652. PubMed ID: 27743068
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of combined oral bisphosphonate therapy and falls prevention exercise for fracture prevention in the USA.
Mori T; Crandall CJ; Ganz DA
Osteoporos Int; 2017 Feb; 28(2):585-595. PubMed ID: 27726000
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of osteoporosis screening strategies for hip fracture prevention in older Chinese people: a decision tree modeling study in the Mr. OS and Ms. OS cohort in Hong Kong.
Su Y; Lai FTT; Yip BHK; Leung JCS; Kwok TCY
Osteoporos Int; 2018 Aug; 29(8):1793-1805. PubMed ID: 29774400
[TBL] [Abstract][Full Text] [Related]
8. Economic evaluation of a population-based osteoporosis intervention for outpatients with non-traumatic non-hip fractures: the "Catch a Break" 1i [type C] FLS.
Majumdar SR; Lier DA; Hanley DA; Juby AG; Beaupre LA;
Osteoporos Int; 2017 Jun; 28(6):1965-1977. PubMed ID: 28275838
[TBL] [Abstract][Full Text] [Related]
9. Simulation-based cost-utility analysis of population screening-based alendronate use in Switzerland.
Schwenkglenks M; Lippuner K
Osteoporos Int; 2007 Nov; 18(11):1481-91. PubMed ID: 17530156
[TBL] [Abstract][Full Text] [Related]
10. Clinical Outcomes and Cost-Effectiveness of Osteoporosis Screening With Dual-Energy X-ray Absorptiometry.
Hsu CL; Wu PC; Yin CH; Chen CH; Lee KT; Lin CL; Shi HY
Korean J Radiol; 2023 Dec; 24(12):1249-1259. PubMed ID: 38016684
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of Virtual Bone Strength Testing in Osteoporosis Screening Programs for Postmenopausal Women in the United States.
Agten CA; Ramme AJ; Kang S; Honig S; Chang G
Radiology; 2017 Nov; 285(2):506-517. PubMed ID: 28613988
[TBL] [Abstract][Full Text] [Related]
12. Impact of generic alendronate cost on the cost-effectiveness of osteoporosis screening and treatment.
Nayak S; Roberts MS; Greenspan SL
PLoS One; 2012; 7(3):e32879. PubMed ID: 22427903
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of denosumab versus oral alendronate for elderly osteoporotic women in Japan.
Mori T; Crandall CJ; Ganz DA
Osteoporos Int; 2017 May; 28(5):1733-1744. PubMed ID: 28210776
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of single-dose zoledronic acid for nursing home residents with osteoporosis in the USA.
Ito K
BMJ Open; 2018 Sep; 8(9):e022585. PubMed ID: 30181186
[TBL] [Abstract][Full Text] [Related]
15. Evidence to inform decision makers in Thailand: a cost-effectiveness analysis of screening and treatment strategies for postmenopausal osteoporosis.
Kingkaew P; Maleewong U; Ngarmukos C; Teerawattananon Y
Value Health; 2012; 15(1 Suppl):S20-8. PubMed ID: 22265062
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness analysis of hip fracture prevention with vitamin D supplementation: a Markov micro-simulation model applied to the French population over 65 years old without previous hip fracture.
Zarca K; Durand-Zaleski I; Roux C; Souberbielle JC; Schott AM; Thomas T; Fardellone P; Benhamou CL
Osteoporos Int; 2014 Jun; 25(6):1797-806. PubMed ID: 24691648
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of a fracture liaison service--a real-world evaluation after 6 years of service provision.
Yong JH; Masucci L; Hoch JS; Sujic R; Beaton D
Osteoporos Int; 2016 Jan; 27(1):231-40. PubMed ID: 26275439
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of two inexpensive postfracture osteoporosis interventions: results of a randomized trial.
Majumdar SR; Lier DA; Leslie WD
J Clin Endocrinol Metab; 2013 May; 98(5):1991-2000. PubMed ID: 23596140
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of bone densitometry among Caucasian women and men without a prior fracture according to age and body weight.
Schousboe JT; Gourlay M; Fink HA; Taylor BC; Orwoll ES; Barrett-Connor E; Melton LJ; Cummings SR; Ensrud KE;
Osteoporos Int; 2013 Jan; 24(1):163-77. PubMed ID: 22349916
[TBL] [Abstract][Full Text] [Related]
20. Action Seniors! Cost-Effectiveness Analysis of a Secondary Falls Prevention Strategy Among Community-Dwelling Older Fallers.
Davis JC; Khan KM; Hsu CL; Chan P; Cook WL; Dian L; Liu-Ambrose T
J Am Geriatr Soc; 2020 Sep; 68(9):1988-1997. PubMed ID: 32472567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
